Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy
Authors:
- Matti AaproMAMatti Aapro
- Matthias SchwenkglenksMSMatthias Schwenkglenks
- Gary H. LymanGLGary H. Lyman
- Antonio Lopez PousaAPAntonio Lopez Pousa
- Susan LawrinsonSLSusan Lawrinson
- Tomas SkacelTSTomas Skacel
- Pamela BaconPBPamela Bacon
- Gunter von MinckwitzGMGunter von Minckwitz
- 30 June 2010
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 74 (3) , 203-210
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Role of colony stimulating factors (CSFs) in solid tumours: Results of an expert panelCritical Reviews in Oncology/Hematology, 2007
- Impact of Primary Prophylaxis With Granulocyte Colony-Stimulating Factor on Febrile Neutropenia and Mortality in Adult Cancer Patients Receiving Chemotherapy: A Systematic ReviewJournal of Clinical Oncology, 2007
- Hematopoietic growth factors: ESMO Recommendations for the applicationAnnals of Oncology, 2007
- EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumoursEuropean Journal of Cancer, 2006
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Impact of chemotherapy dose-related factors on survival in breast cancer patients treated with adjuvant anthracycline-based chemotherapyJournal of Clinical Oncology, 2006
- Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsCancer, 2006
- Relative dose intensity (RDI) relevance in adjuvant CMF chemotherapy of breast cancerEuropean Journal of Cancer Supplements, 2006
- 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort studyBMJ, 2005
- A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity.Journal of Clinical Oncology, 1998